HemoShear Therapeutics
Developing new treatments for rare metabolic disorders
27 employees · est. 2008 · Charlottesville, United Stat...
RiboNova, Inc.
Focused on Mitochondrial Disease & other serious rare diseases. R007 is our P2 ready asset, we also have tRNA discovery.
7 employees · est. 2011 · Wynnewood, United States
HemoShear Therapeutics is the older company (2008 vs 2011); HemoShear Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | HemoShear Therapeutics | RiboNova, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2011 |
| Headquarters | ||
| Headquarters | Charlottesville, United States | Wynnewood, United States |
| Employees | ||
| Employees | 27 larger | 7 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Debt Financing | Series Unknown |
| Total Funding | ||
| Total Funding | $54.95M | $25.00K |
| Funding Rounds | ||
| Funding Rounds | 8 | 2 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Metabolic Disorders, Rare Diseases, Human Disease Models, Tissue Engineering, Pharmaceutical Partnerships, Clinical Success, Genetic Defects, Liver Diseases, Treatment Development | Biopharmaceutical Company, Rare Diseases, Mitochondrial Disease, Treatment, Drug Discovery, Precision Medicine, TRNA, Genetic Diagnosis, DNA Sequencing, Ribonucleic Acid, Clinical Biomarkers, Therapeutic Targets, Translational Medicine, Phase-2 Ready Drug |
| Website | ||
| Website | hemoshear.com | ribonova.com |
About HemoShear Therapeutics
HemoShear Therapeutics is a biotechnology company with a focus on developing new treatments for rare metabolic disorders. Established in 2008, the company utilizes a proprietary technology that allows them to recapitulate diseases using tissue from livers of children born with genetic defects. This...
About RiboNova, Inc.
RiboNova, Inc. is a biopharmaceutical company founded in 2011, with a primary focus on developing treatments for mitochondrial disease and other serious rare diseases. The company's flagship asset, R007, is a Phase-2 ready small molecule drug designed to address all forms of genetically-confirmed mi...
We will tell you when either one moves
BounceWatch watches HemoShear Therapeutics and RiboNova, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at HemoShear Therapeutics and RiboNova, Inc. — by email.
Frequently Asked Questions
Compare HemoShear Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at HemoShear Therapeutics on 12 Sep 2024, and RiboNova, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
